Development of a Sheep Model for GM3 Synthase Deficiency Through CRISPR-Cas9 Technology

被引:0
|
作者
Benatti, Hector Ribeiro [1 ]
Gallagher, Jillian [1 ]
Gately, Rachael [2 ]
Gallant, Judith [3 ]
Xu, Ping [3 ]
Baker, William C. [1 ]
Bertrand, Stephanie [2 ]
McElroy, Abigail [1 ]
Hall, Erin [1 ]
Taghian, Toloo [1 ]
Jiang, Xuntian [4 ]
Parsley, Elizabeth [2 ]
Strauss, Kevin A. [5 ]
Rivera, Jaime [3 ]
Gray-Edwards, Heather [1 ]
机构
[1] Univ Massachusetts, Horae Gene Therapy Ctr, Med Sch, Worcester, MA 01605 USA
[2] Tufts Univ, Sch Vet Med, 200 Westboro Rd, North Grafton, MA 01536 USA
[3] Univ Massachusetts, Transgen Anim Modeling Core, Med Sch, Worcester, MA 01605 USA
[4] Washington Univ, Sch Med, St Louis, MO 63110 USA
[5] Clin Special Children, Strasburg, PA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1028
引用
收藏
页码:481 / 482
页数:2
相关论文
共 50 条
  • [1] Development of a Sheep Model of Adrenoleukodystrophy (ALD) Using CRISPR-Cas9 Technology
    Hall, Erin F.
    Gallagher, Jillian M.
    Taghian, Toloo
    McElroy, Abigail W.
    Benatti, Hector R.
    Baker, William C.
    Gallant, Judith
    Xu, Ping
    Rivera, Jaime
    Eichler, Florian
    Bertrand, Stephanie
    Gately, Rachael
    Gray-Edwards, Heather
    MOLECULAR THERAPY, 2022, 30 (04) : 482 - 482
  • [2] Glioblastoma animal model using CRISPR-Cas9 technology
    Jeong, Da Eun
    Lee, Kee Hang
    Kim, Sung Soo
    Bae, Yoon Kyung
    Nam, Hyun
    Hwang, Ji Yoon
    Pyeon, Hee Jang
    Song, Hye Jin
    Joo, Kyeung Min
    CANCER RESEARCH, 2017, 77
  • [3] Engineering disease resistant plants through CRISPR-Cas9 technology
    Tyagi, Swati
    Kumar, Robin
    Kumar, Vivak
    Won, So Youn
    Shukla, Pratyoosh
    GM CROPS & FOOD-BIOTECHNOLOGY IN AGRICULTURE AND THE FOOD CHAIN, 2021, 12 (01): : 125 - 144
  • [4] Dystonia due to GM3 synthase deficiency
    Wang, A.
    Kilbane, C.
    MOVEMENT DISORDERS, 2021, 36 : S514 - S515
  • [5] Dystonia Due to GM3 Synthase Deficiency
    Wang, Alexander S.
    Kilbane, Camilla
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (02): : 236 - 239
  • [6] Application of CRISPR-Cas9 technology in diabetes research
    Lotfi, Malihe
    Butler, Alexandra E.
    Sukhorukov, Vasily N.
    Sahebkar, Amirhossein
    DIABETIC MEDICINE, 2024, 41 (01)
  • [7] Trends in CRISPR-Cas9 technology application in cancer
    Mukhopadhyay, Subhadip
    Bhutia, Sujit Kumar
    ADVANCES IN CRISPR/CAS AND RELATED TECHNOLOGIES, 2021, 178 : 175 - 192
  • [8] A glance at genome editing with CRISPR-Cas9 technology
    Barman, Antara
    Deb, Bornali
    Chakraborty, Supriyo
    CURRENT GENETICS, 2020, 66 (03) : 447 - 462
  • [9] Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
    Liu, Tang
    Shen, Jacson K.
    Li, Zhihong
    Choy, Edwin
    Hornicek, Francis J.
    Duan, Zhenfeng
    CANCER LETTERS, 2016, 373 (01) : 109 - 118
  • [10] Leveraging CRISPR-Cas9 Technology for Biopharmaceutical Development: Challenges and Market Opportunities
    Anderson, Angela
    Journal of Commercial Biotechnology, 2024, 29 (04): : 23 - 31